MENU
JUN 20, 2019 7:30 AM PDT

Keynote Presentation: The Impact of Patient-to-Patient Variability on Combination Cancer Therapy and Precision Oncology

Speaker

Abstract

Most cancer therapies have highly variable activity from one patient to another, with only a fraction of patients’ cancers responding to a given treatment. In many types of cancer, combination therapies can improve the probability of response. Since 1961 it was known that combinations of individually active therapies can be expected to improve response rate to some degree simply by increasing each patient’s chance of receiving at least one personally effective therapy. Here I describe recent analyses of contemporary combination therapies showing that this phenomenon of patient-to-patient variability in single-drug activity accounts for the clinical activity of many approved combination cancer therapies. These results highlight widespread opportunities to make more precise use of cancer therapies both individually and in combinations.

Learning Objectives: 

1. How patient-to-patient variability in response to individual cancer therapies affects responses to combinations of cancer therapies, and the implications for precision medicine in oncology.
2. How to calculate the 'independent effect' Progression Free Survival distribution for a combination of cancer therapies, which can be used to analyze clinical trial results, and to predict the activity of combinations of independently acting drugs.


Show Resources
You May Also Like
SEP 14, 2021 7:00 AM PDT
C.E. CREDITS
SEP 14, 2021 7:00 AM PDT
Date: September 14, 2021 Time: 7am PDT, 10am EDT, 4pm CEST A conventional thermal cycler has long been a commodity product in the lab and end-point PCR techniques can be completed almost wit...
SEP 17, 2021 12:00 PM CST
C.E. CREDITS
SEP 17, 2021 12:00 PM CST
Date: September 16, 2021 Time: 9:00pm (PDT), 12:00am (EDT) 3D cellular models like organoids and spheroids offer an opportunity to better understand complex biology in a physiologically rele...
JUN 09, 2021 7:00 AM PDT
C.E. CREDITS
JUN 09, 2021 7:00 AM PDT
Date: June 9, 2021 Time: 09 June 2021, 7am PDT, 10am EDT, 4pm CEST cells with dramatic implications on the validity of past cell culture related research. The fact that at least 509 cell lin...
OCT 20, 2021 10:00 AM PDT
C.E. CREDITS
OCT 20, 2021 10:00 AM PDT
Date: October 20, 2021 Time:10:00am (PDT), 1:00pm (EDT) As the prevalence of Diabetes continues to rise in many areas across the globe, healthcare providers continue to look for methods that...
NOV 09, 2021 11:00 AM PST
C.E. CREDITS
NOV 09, 2021 11:00 AM PST
Date: November 09, 2021 Time: 11:00am (PDT), 02:00pm (EDT) Clinical translation of human pluripotent stem cells (hPSCs) requires advanced strategies that ensure safe and robust long-term gro...
NOV 30, 2021 10:00 AM PST
C.E. CREDITS
NOV 30, 2021 10:00 AM PST
Date: November 30, 2021 Time: 10:00am (PDT), 1:00pm (EDT) The prevalence of thyroid disease worldwide has served as a catalyst for healthcare providers to study various tools and methods to...
JUN 20, 2019 7:30 AM PDT

Keynote Presentation: The Impact of Patient-to-Patient Variability on Combination Cancer Therapy and Precision Oncology



Show Resources
Loading Comments...
Show Resources